Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease

Sankar D Navaneethan1, Jesse D Schold2, Stacey E Jolly3

  • 1Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.

Kidney International
|July 29, 2017
PubMed

Insights

In patients with chronic kidney disease (CKD), both low and high systolic blood pressure are linked to increased cardiovascular mortality. Low diastolic blood pressure also increases non-cardiovascular mortality risk.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Previous studies suggest J or U-shaped relationships between blood pressure and mortality in chronic kidney disease (CKD).
  • Understanding these associations is crucial for managing hypertension in CKD patients.

Purpose of the Study:

  • To investigate the associations between different blood pressure levels and various causes of death in a CKD population.
  • To analyze mortality risks associated with specific systolic and diastolic blood pressure ranges.

Main Methods:

  • Utilized data from State Department of Health mortality files for a cohort of 45,412 CKD patients (eGFR 15-59 ml/min/1.73 m²).
  • Employed Cox and competing risk regression models to assess mortality causes (cardiovascular, malignancy, other).
  • Followed patients for a median of 3.9 years, during which 13,332 deaths occurred.

Main Results:

  • Systolic blood pressure <110 mmHg and >150 mmHg were associated with increased all-cause and cardiovascular mortality.
  • Systolic blood pressure <100-109 mmHg correlated with higher non-cardiovascular/non-malignancy mortality.
  • Diastolic blood pressure <60 mmHg linked to higher all-cause and non-cardiovascular/non-malignancy mortality.
  • Diastolic blood pressure >90 mmHg associated with higher cardiovascular mortality but lower non-cardiovascular/non-malignancy mortality.

Conclusions:

  • In non-dialysis CKD patients, both very low (<110 mmHg) and very high (>150 mmHg) systolic blood pressures increase cardiovascular and non-cardiovascular/non-malignancy mortality.
  • Low diastolic blood pressure (<60 mmHg) is associated with increased all-cause and non-cardiovascular/non-malignancy mortality.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
834
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
508
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
455
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
768
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
279